Stay updated on SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial
Sign up to get notified when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.

Latest updates to the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page
- Check3 days agoChange DetectedRevision updated to v3.5.5, indicating a patch-level update to the page. There are no substantive content changes associated with this revision.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, marking a new build of the page. This appears to be a version update rather than a content modification.SummaryDifference0.0%

- Check46 days agoChange DetectedA newer ClinicalTrials.gov page revision is now shown compared with the previous revision label.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No visible changes to the trial details content or layout were observed, indicating an internal update.SummaryDifference0.0%

- Check97 days agoChange DetectedRevision updated to v3.4.3; the previous v3.4.2 tag was removed.SummaryDifference0.0%

- Check118 days agoChange DetectedRevision: v3.4.2 is now displayed, replacing Revision: v3.4.1. No core study details or results appear to be altered.SummaryDifference0.0%

Stay in the know with updates to SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.